Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 109

Similar articles for PubMed (Select 24604109)

1.

The metastasis suppressor SOX11 is an independent prognostic factor for improved survival in gastric cancer.

Qu Y, Zhou C, Zhang J, Cai Q, Li J, Du T, Zhu Z, Cui X, Liu B.

Int J Oncol. 2014 May;44(5):1512-20. doi: 10.3892/ijo.2014.2328. Epub 2014 Mar 6.

2.

Aberrant SOX11 promoter methylation is associated with poor prognosis in gastric cancer.

Xu X, Chang X, Li Z, Wang J, Deng P, Zhu X, Liu J, Zhang C, Chen S, Dai D.

Cell Oncol (Dordr). 2015 Jun;38(3):183-94. doi: 10.1007/s13402-015-0219-7. Epub 2015 Mar 24.

PMID:
25801783
3.

Rac1 is correlated with aggressiveness and a potential therapeutic target for gastric cancer.

Ji J, Feng X, Shi M, Cai Q, Yu Y, Zhu Z, Zhang J.

Int J Oncol. 2015 Mar;46(3):1343-53. doi: 10.3892/ijo.2015.2836. Epub 2015 Jan 13.

PMID:
25585795
4.

Increased expression of pleiotrophin is a prognostic marker for patients with gastric cancer.

Hu H, Li C, Cai S, Zhu C, Tian Y, Zheng J, Hu J, Chen C, Liu W.

Hepatogastroenterology. 2014 Jul-Aug;61(133):1478-82.

PMID:
25436328
5.

The SOX11-PDGFA axis in mantle cell lymphoma.

Hsi ED.

Blood. 2014 Oct 2;124(14):2165-6. doi: 10.1182/blood-2014-08-595454. No abstract available.

PMID:
25278565
6.

SOX11 promotes tumor angiogenesis through transcriptional regulation of PDGFA in mantle cell lymphoma.

Palomero J, Vegliante MC, Rodríguez ML, Eguileor A, Castellano G, Planas-Rigol E, Jares P, Ribera-Cortada I, Cid MC, Campo E, Amador V.

Blood. 2014 Oct 2;124(14):2235-47. doi: 10.1182/blood-2014-04-569566. Epub 2014 Aug 4.

PMID:
25092176
7.

Clinical and prognostic significance of SOX11 in breast cancer.

Liu DT, Peng-Zhao, Han JY, Lin FZ, Bu XM, Xu QX.

Asian Pac J Cancer Prev. 2014;15(13):5483-6.

8.

Odd-skipped related 1 is a novel tumour suppressor gene and a potential prognostic biomarker in gastric cancer.

Otani K, Dong Y, Li X, Lu J, Zhang N, Xu L, Go MY, Ng EK, Arakawa T, Chan FK, Sung JJ, Yu J.

J Pathol. 2014 Nov;234(3):302-15. doi: 10.1002/path.4391. Epub 2014 Aug 28.

9.

Sineoculis homeobox homolog 1 protein as an independent biomarker for gastric adenocarcinoma.

Lv H, Cui A, Sun F, Zhang Y, Li Y, Li L, Lin Z.

Exp Mol Pathol. 2014 Aug;97(1):74-80. doi: 10.1016/j.yexmp.2014.05.007. Epub 2014 May 24.

PMID:
24866365
10.

[Expression of SOX11 transcription factor. Its implication in mantle cell lymphoma].

Roisman A, Slavutsky I.

Medicina (B Aires). 2014;74(2):140-6. Spanish.

11.

Down-regulation of Sox11 is required for efficient osteogenic differentiation of adipose-derived stem cells.

Choi MK, Seong I, Kang SA, Kim J.

Mol Cells. 2014 Apr;37(4):337-44. doi: 10.14348/molcells.2014.0021. Epub 2014 Apr 7.

12.

S100A6 as a potential serum prognostic biomarker and therapeutic target in gastric cancer.

Zhang J, Zhang K, Jiang X, Zhang J.

Dig Dis Sci. 2014 Sep;59(9):2136-44. doi: 10.1007/s10620-014-3137-z. Epub 2014 Apr 5.

PMID:
24705642
13.

High-resolution chromatin immunoprecipitation (ChIP) sequencing reveals novel binding targets and prognostic role for SOX11 in mantle cell lymphoma.

Kuo PY, Leshchenko VV, Fazzari MJ, Perumal D, Gellen T, He T, Iqbal J, Baumgartner-Wennerholm S, Nygren L, Zhang F, Zhang W, Suh KS, Goy A, Yang DT, Chan WC, Kahl BS, Verma AK, Gascoyne RD, Kimby E, Sander B, Ye BH, Melnick AM, Parekh S.

Oncogene. 2015 Mar 5;34(10):1231-40. doi: 10.1038/onc.2014.44. Epub 2014 Mar 31.

PMID:
24681958
14.

NEDD9 overexpression correlates with poor prognosis in gastric cancer.

Liu Y, Wang D, Zhao KL, Zhu JW, Yin HB, Wei YZ, Wu ZJ, Cheng GJ, Wang F, Ni F, Wang XL, Cao GX, Huang J, Cai J.

Tumour Biol. 2014 Jul;35(7):6351-6. doi: 10.1007/s13277-014-1839-7. Epub 2014 Mar 25.

PMID:
24664584
15.

Clinical significance of polypeptide N-acetylgalactosaminyl transferase-5 (GalNAc-T5) expression in patients with gastric cancer.

He H, Shen Z, Zhang H, Wang X, Tang Z, Xu J, Sun Y.

Br J Cancer. 2014 Apr 15;110(8):2021-9. doi: 10.1038/bjc.2014.93. Epub 2014 Mar 11.

16.

Expression characteristics of CDC20 in gastric cancer and its correlation with poor prognosis.

Ding ZY, Wu HR, Zhang JM, Huang GR, Ji DD.

Int J Clin Exp Pathol. 2014 Jan 15;7(2):722-7. eCollection 2014.

17.

Prognostic relevance of Period1 (Per1) and Period2 (Per2) expression in human gastric cancer.

Zhao H, Zeng ZL, Yang J, Jin Y, Qiu MZ, Hu XY, Han J, Liu KY, Liao JW, Xu RH, Zou QF.

Int J Clin Exp Pathol. 2014 Jan 15;7(2):619-30. eCollection 2014.

18.

The expression of claudin 1 correlates with β-catenin and is a prognostic factor of poor outcome in gastric cancer.

Huang J, Li J, Qu Y, Zhang J, Zhang L, Chen X, Liu B, Zhu Z.

Int J Oncol. 2014 Apr;44(4):1293-301. doi: 10.3892/ijo.2014.2298. Epub 2014 Feb 12.

PMID:
24535143
19.

NEDD9 overexpression correlates with the progression and prognosis in gastric carcinoma.

Shi R, Wang L, Wang T, Xu J, Wang F, Xu M.

Med Oncol. 2014 Mar;31(3):852. doi: 10.1007/s12032-014-0852-4. Epub 2014 Jan 28.

PMID:
24469954
20.

Overexpression of kallikrein gene 10 is a biomarker for predicting poor prognosis in gastric cancer.

Jiao X, Lu HJ, Zhai MM, Tan ZJ, Zhi HN, Liu XM, Liu CH, Zhang DP.

World J Gastroenterol. 2013 Dec 28;19(48):9425-31. doi: 10.3748/wjg.v19.i48.9425.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk